Tenderfy

NP47827 Multiple Sclerosis Medicines

Hankija
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
Avaldatud
2026-10-26
Tähtaeg
Pole esitatud
Allikad
UK_FTS
Väärtus
30403887.0 GBP

Kirjeldus

Kirjeldus on allika keeles.

The Authority seeks to establish a Framework Agreement covering Multiple Sclerosis medicines. The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape): Glatiramer acetate Interferon beta-1a Teriflunomide Dimethyl fumarate Fingolimod Natalizumab Cladribine

CPV: 33600000

Liikmesus

Teadete eelvaated on tasuta. Ametlike teadete ja dokumentide lingid, ehitusload ning isiklik MCP juurdepääs nõuavad aktiivset tasulist liikmesust.

Loe